A detailed history of Black Rock Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,835,243 shares of HRMY stock, worth $199 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,835,243
Previous 5,922,761 1.48%
Holding current value
$199 Million
Previous $199 Million 11.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$28.81 - $33.01 $2.52 Million - $2.89 Million
-87,518 Reduced 1.48%
5,835,243 $176 Million
Q1 2024

May 10, 2024

SELL
$29.93 - $35.06 $2.41 Million - $2.82 Million
-80,566 Reduced 1.34%
5,922,761 $199 Million
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $2.48 Million - $4.36 Million
-129,160 Reduced 2.11%
6,003,327 $194 Million
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $12.2 Million - $14.9 Million
382,009 Added 6.64%
6,132,487 $201 Million
Q2 2023

Aug 11, 2023

BUY
$30.5 - $37.4 $24.1 Million - $29.6 Million
790,338 Added 15.93%
5,750,478 $202 Million
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $2.78 Million - $4.87 Million
90,358 Added 1.86%
4,960,140 $162 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $3.07 Million - $4.12 Million
67,669 Added 1.41%
4,869,782 $268 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $34.9 Million - $46 Million
829,234 Added 20.87%
4,802,113 $213 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $4.69 Million - $7.3 Million
139,960 Added 3.65%
3,972,879 $194 Million
Q1 2022

May 12, 2022

BUY
$33.14 - $51.13 $3.09 Million - $4.76 Million
93,153 Added 2.49%
3,832,919 $186 Million
Q4 2021

Feb 10, 2022

BUY
$34.09 - $43.91 $72.5 Million - $93.3 Million
2,125,593 Added 131.68%
3,739,766 $159 Million
Q3 2021

Nov 09, 2021

BUY
$25.68 - $38.61 $7.95 Million - $11.9 Million
309,428 Added 23.72%
1,614,173 $61.9 Million
Q2 2021

Aug 11, 2021

BUY
$25.96 - $33.44 $33.9 Million - $43.6 Million
1,304,745 New
1,304,745 $36.8 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.